Chitosan-based nanocomplexes for simultaneous loading, burst reduction and controlled release of doxorubicin and 5-fluorouracil
Open Access
- 1 September 2017
- journal article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 102, 613-624
Abstract
No abstract availableKeywords
Funding Information
- Ministerstvo Školství, Mládeže a Tělovýchovy (CZ.1.05/2.1.00/19.0409, LO1504)
- Grantová Agentura České Republiky (15-08287Y)
This publication has 45 references indexed in Scilit:
- In Vitro Delivery and Controlled Release of Doxorubicin for Targeting Osteosarcoma Bone CancerMolecules, 2013
- Real time in vitro studies of doxorubicin release from PHEMA nanoparticlesJournal of Nanobiotechnology, 2009
- Quantitation of 5‐fluorouracil (5‐FU) in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometryRapid Communications in Mass Spectrometry, 2007
- Effect of the microencapsulation of nanoparticles on the reduction of burst releaseInternational Journal of Pharmaceutics, 2007
- Microwave‐Assisted Single‐Step Synthesis of Poly(lactic acid) by Direct Polycondensation of Lactic AcidMacromolecular Rapid Communications, 2007
- Freeze-drying of nanoparticles: Formulation, process and storage considerations☆Advanced Drug Delivery Reviews, 2006
- Determination of 5-Fluorouracil in Plasma with HPLC-Tandem Mass SpectrometryNucleosides, Nucleotides & Nucleic Acids, 2006
- Formulation and investigation of 5-FU nanoparticles with factorial design-based studiesIl Farmaco, 2005
- Chitosan nanoparticles as delivery systems for doxorubicinJournal of Controlled Release, 2001
- NMR Analysis of Low Molecular Weight Poly(lactic acid)sMacromolecules, 1996